Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 94.6B | 97.7B | 95.4B | 91.2B |
Cost of revenue | 80.2B | 84.8B | 82.9B | 77.9B |
Gross profit | 14.4B | 12.9B | 12.6B | 13.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 11.0B | 10.4B | 10.6B | 10.3B |
Operating income | 3.4B | 2.5B | 2.0B | 3.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 785M | 758M | 752M | 732M |
Other income expense | 28M | 406M | -1.1B | 24M |
Pretax income | 2.6B | 2.1B | 105M | 2.3B |
Tax provision | 835M | 503M | 34M | 569M |
Net income | 1.8B | 1.6B | 71M | 1.8B |
Basic EPS | 1.4 | 1.3 | 0.1 | 1.4 |
Diluted EPS | 1.4 | 1.3 | 0.1 | 1.4 |
Basic average shares | 1.4B | 1.4B | 1.4B | 1.4B |
Diluted average shares | 1.4B | 1.4B | 1.4B | 1.4B |
EBITDA | 4.6B | 3.7B | 3.2B | 4.2B |
Net income from continuing op. | 1.8B | 1.6B | 71M | 1.8B |
Minority interests | -3M | 21M | 16M | 2M |
Preferred stock dividends | — | — | — | — |